Total Payments
$6,541
2024 Payments
$608.93
Companies
26
Transactions
325
Medicare Patients
7,090
Medicare Billing
$423,147
Payment Breakdown by Category
Food & Beverage$6,115 (93.5%)
Travel$394.30 (6.0%)
Education$31.28 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,115 | 320 | 93.5% |
| Travel and Lodging | $394.30 | 2 | 6.0% |
| Education | $31.28 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,387 | 69 | $0 (2024) |
| Boston Scientific Corporation | $492.50 | 28 | $0 (2024) |
| PFIZER INC. | $488.06 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $469.68 | 27 | $0 (2023) |
| Amgen Inc. | $404.28 | 23 | $0 (2024) |
| Medtronic Vascular, Inc. | $400.32 | 12 | $0 (2019) |
| BIOTRONIK INC. | $393.96 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $368.08 | 18 | $0 (2024) |
| Medical Device Business Services, Inc. | $355.26 | 4 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $287.87 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $608.93 | 29 | Daiichi Sankyo Inc. ($97.07) |
| 2023 | $661.37 | 34 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($92.08) |
| 2022 | $812.56 | 34 | Medtronic, Inc. ($172.72) |
| 2021 | $235.61 | 13 | Janssen Pharmaceuticals, Inc ($74.07) |
| 2020 | $396.26 | 25 | Janssen Pharmaceuticals, Inc ($99.75) |
| 2019 | $1,427 | 68 | Janssen Pharmaceuticals, Inc ($358.60) |
| 2018 | $1,488 | 66 | Janssen Pharmaceuticals, Inc ($406.38) |
| 2017 | $910.19 | 56 | Janssen Pharmaceuticals, Inc ($307.68) |
All Payment Transactions
325 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Not Applicable | ||||||
| 11/06/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/31/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.27 | General |
| Category: Cardiovascular | ||||||
| 10/01/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Not Applicable | ||||||
| 08/27/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/23/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardiology | ||||||
| 07/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/12/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Pacemakers | ||||||
| 06/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiology | ||||||
| 06/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.68 | General |
| Category: Cardiovascular | ||||||
| 05/31/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Stents | ||||||
| 05/31/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/12/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/20/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,682 | 4,731 | $480,357 | $146,326 |
| 2022 | 22 | 1,519 | 1,689 | $237,918 | $90,102 |
| 2021 | 26 | 1,819 | 2,167 | $261,978 | $105,956 |
| 2020 | 26 | 1,070 | 1,220 | $205,383 | $80,763 |
Total Patients
7,090
Total Services
9,807
Medicare Billing
$423,147
Procedure Codes
107
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 305 | 404 | $73,389 | $35,374 | 48.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 425 | 956 | $68,832 | $18,847 | 27.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 574 | 1,291 | $87,788 | $18,565 | 21.1% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 32 | 32 | $34,912 | $12,628 | 36.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 237 | 273 | $29,967 | $9,711 | 32.4% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 133 | 343 | $29,498 | $8,363 | 28.4% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 157 | 351 | $48,789 | $8,295 | 17.0% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 131 | 341 | $19,778 | $6,048 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $10,594 | $4,232 | 40.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 28 | $6,919 | $3,751 | 54.2% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 12 | 12 | $8,952 | $3,024 | 33.8% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 45 | 48 | $8,132 | $2,302 | 28.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 39 | 39 | $5,499 | $1,998 | 36.3% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 46 | 54 | $5,018 | $1,664 | 33.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 85 | 87 | $4,698 | $1,622 | 34.5% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 30 | 32 | $4,917 | $1,607 | 32.7% |
| 33285 | Insertion of heart rhythm monitor under skin | Facility | 2023 | 24 | 24 | $4,440 | $1,499 | 33.8% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 32 | 36 | $4,428 | $1,496 | 33.8% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 68 | 68 | $3,808 | $888.46 | 23.3% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 69 | 69 | $6,624 | $857.40 | 12.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 23 | 43 | $2,193 | $811.42 | 37.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 55 | 58 | $3,074 | $609.32 | 19.8% |
| 33286 | Removal of heart rhythm monitor from under the skin | Facility | 2023 | 13 | 13 | $2,353 | $601.51 | 25.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 11 | 11 | $2,343 | $534.78 | 22.8% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 11 | 11 | $1,489 | $384.20 | 25.8% |
About Dr. Robert Stevenson, M.D
Dr. Robert Stevenson, M.D is a Cardiovascular Disease healthcare provider based in Lebanon, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1225244684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Stevenson, M.D has received a total of $6,541 in payments from pharmaceutical and medical device companies, with $608.93 received in 2024. These payments were reported across 325 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,115).
As a Medicare-enrolled provider, Stevenson has provided services to 7,090 Medicare beneficiaries, totaling 9,807 services with total Medicare billing of $423,147. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Lebanon, PA
- Active Since 05/15/2007
- Last Updated 02/08/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1225244684
Products in Payments
- XARELTO (Drug) $1,387
- ELIQUIS (Drug) $444.75
- ENTRESTO (Drug) $317.17
- Micra (Device) $310.95
- Repatha (Biological) $293.34
- JARDIANCE (Drug) $274.71
- LifeVest (Device) $246.06
- BRILINTA (Drug) $197.65
- INJECTAFER (Drug) $195.67
- PRADAXA (Drug) $194.97
- CHANTIX (Drug) $164.33
- LINQ II (Device) $145.74
- Acticor 7 VR-T DX (Device) $129.47
- Corlanor (Drug) $110.94
- Edora 8 DR-T (Device) $107.58
- Resolute (Device) $90.16
- FARXIGA (Drug) $71.22
- PRALUENT ALIROCUMAB INJECTION (Biological) $63.24
- KENGREAL (Drug) $59.59
- ONYX FRONTIER (Device) $53.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lebanon
Dr. Emily Zeitler, Md, MD
Cardiovascular Disease — Payments: $166,924
Cardiovascular Disease $166,924
Andre Olivier, Md, MD
Cardiovascular Disease — Payments: $155,216
Cardiovascular Disease $155,216
Robert Woods, M.d, M.D
Cardiovascular Disease — Payments: $64,184
Cardiovascular Disease $64,184
Dr. Merle Myerson, Md, MD
Cardiovascular Disease — Payments: $48,844
Cardiovascular Disease $48,844
Dr. Rajbir Sangha, Mb Chb, MB CHB
Cardiovascular Disease — Payments: $43,680
Cardiovascular Disease $43,680
Dr. Samuel Kolman, Md, MD
Cardiovascular Disease — Payments: $35,366
Cardiovascular Disease $35,366